Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats

MM Conti, SM Meadows, M Melikhov-Sosin… - …, 2016 - Elsevier
Abstract l-DOPA is the standard treatment for Parkinson's disease (PD), but chronic
treatment typically leads to abnormal involuntary movement or dyskinesia (LID) …
被引用次数：32 相关文章
[PDF] wordpress.com

[PDF][PDF] Monoamine transporter contributions to L-DOPA effects in hemi-parkinsonian rats

MM Conti, SM Meadows… - …, 2016 - cbishoplab.wordpress.com
abstract L-DOPA is the standard treatment for Parkinson's disease (PD), but chronic
treatment typically leads to abnormal involuntary movement or dyskinesia (LID) …

Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats

MM Conti, SM Meadows, M Melikhov-Sosin… - …, 2016 - infona.pl
l-DOPA is the standard treatment for Parkinson's disease (PD), but chronic treatment
typically leads to abnormal involuntary movement or dyskinesia (LID) development …

Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.

MM Conti, SM Meadows, M Melikhov-Sosin… - …, 2016 - europepmc.org
l-DOPA is the standard treatment for Parkinson's disease (PD), but chronic treatment
typically leads to abnormal involuntary movement or dyskinesia (LID) development …

Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats

MM Conti, SM Meadows… - …, 2016 - pubmed.ncbi.nlm.nih.gov
l-DOPA is the standard treatment for Parkinson's disease (PD), but chronic treatment
typically leads to abnormal involuntary movement or dyskinesia (LID) development …